ELANCO ANIMAL HEALTH.ELANCO ANIMAL HEALTH.ELANCO ANIMAL HEALTH.

ELANCO ANIMAL HEALTH.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.66 B‬EUR
0.370EUR
‪−1.12 B‬EUR
‪4.00 B‬EUR
‪488.23 M‬
Beta (1Y)
1.68

About Elanco Animal Health Incorporated


CEO
Jeffrey N. Simmons
Website
Headquarters
Greenfield
Founded
1954
FIGI
BBG00MH8HL55
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BER exchange ELANCO ANIMAL HEALTH. stocks are traded under the ticker 5EA.
We've gathered analysts' opinions on ELANCO ANIMAL HEALTH. future price: according to them, 5EA price has a max estimate of 19.77 EUR and a min estimate of 14.12 EUR. Watch 5EA chart and read a more detailed ELANCO ANIMAL HEALTH. stock forecast: see what analysts think of ELANCO ANIMAL HEALTH. and suggest that you do with its stocks.
5EA reached its all-time high on Nov 13, 2018 with the price of 31.560 EUR, and its all-time low was 7.390 EUR and was reached on May 25, 2023. View more price dynamics on 5EA chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ELANCO ANIMAL HEALTH. financials in yearly and quarterly reports right on TradingView.
ELANCO ANIMAL HEALTH. is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
5EA earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.11 EUR resulting in a 6.20% surprise. The estimated earnings for the next quarter are 0.15 EUR per share. See more details about ELANCO ANIMAL HEALTH. earnings.
ELANCO ANIMAL HEALTH. revenue for the last quarter amounts to ‪925.09 M‬ EUR, despite the estimated figure of ‪930.73 M‬ EUR. In the next quarter, revenue is expected to reach ‪961.46 M‬ EUR.
5EA net income for the last quarter is ‪326.92 M‬ EUR, while the quarter before that showed ‪−46.68 M‬ EUR of net income which accounts for 800.35% change. Track more ELANCO ANIMAL HEALTH. financial stats to get the full picture.
No, 5EA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has ‪9.80 K‬ employees. See our rating of the largest employees — is ELANCO ANIMAL HEALTH. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELANCO ANIMAL HEALTH. EBITDA is ‪828.09 M‬ EUR, and current EBITDA margin is 23.09%. See more stats in ELANCO ANIMAL HEALTH. financial statements.
Like other stocks, 5EA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELANCO ANIMAL HEALTH. stock right from TradingView charts — choose your broker and connect to your account.